| Dr Bradley Henry Hoffman, DPM | |
|
401 Rogers St, Princeton, WV 24740-3636 | |
| (540) 982-2463 | |
| Not Available |
| Full Name | Dr Bradley Henry Hoffman |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 401 Rogers St, Princeton, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093166076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 10464 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foot And Ankle Clinic Of The Virginias Inc | 7911948583 | 11 |
News Archive
A fellow in the Breast Health Center at Women & Infants Hospital of Rhode Island was one of 25 nationwide to earn a 2011 Breast Cancer Symposium Merit Award from The Conquer Cancer Foundation of the American Society of Clinical Oncology.
King Pharmaceuticals, Inc. announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.
Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes.
Dozens of states are passing or debating new restrictions on abortion, a trend fueled in part by passage of the nation's new health care law. Both sides of the hot-button issue are seeing new approaches to reduce abortions. … So far, 2010 has been 'very successful,' said Mary Spaulding Balch of the National Right to Life Committee.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
› Verified 8 days ago
| Provider Name | Foot And Ankle Clinic Of The Virginias Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1740227909 PECOS PAC ID: 7911948583 Enrollment ID: O20050513000739 |
News Archive
A fellow in the Breast Health Center at Women & Infants Hospital of Rhode Island was one of 25 nationwide to earn a 2011 Breast Cancer Symposium Merit Award from The Conquer Cancer Foundation of the American Society of Clinical Oncology.
King Pharmaceuticals, Inc. announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.
Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes.
Dozens of states are passing or debating new restrictions on abortion, a trend fueled in part by passage of the nation's new health care law. Both sides of the hot-button issue are seeing new approaches to reduce abortions. … So far, 2010 has been 'very successful,' said Mary Spaulding Balch of the National Right to Life Committee.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
› Verified 8 days ago
| Provider Name | West Virginia Foot & Ankle, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245923663 PECOS PAC ID: 0042671661 Enrollment ID: O20230731000219 |
News Archive
A fellow in the Breast Health Center at Women & Infants Hospital of Rhode Island was one of 25 nationwide to earn a 2011 Breast Cancer Symposium Merit Award from The Conquer Cancer Foundation of the American Society of Clinical Oncology.
King Pharmaceuticals, Inc. announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.
Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes.
Dozens of states are passing or debating new restrictions on abortion, a trend fueled in part by passage of the nation's new health care law. Both sides of the hot-button issue are seeing new approaches to reduce abortions. … So far, 2010 has been 'very successful,' said Mary Spaulding Balch of the National Right to Life Committee.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley Henry Hoffman, DPM 528 Sheridan Cir, Charleston, WV 25314-1063 Ph: (814) 360-7414 | Dr Bradley Henry Hoffman, DPM 401 Rogers St, Princeton, WV 24740-3636 Ph: (540) 982-2463 |
News Archive
A fellow in the Breast Health Center at Women & Infants Hospital of Rhode Island was one of 25 nationwide to earn a 2011 Breast Cancer Symposium Merit Award from The Conquer Cancer Foundation of the American Society of Clinical Oncology.
King Pharmaceuticals, Inc. announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.
Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes.
Dozens of states are passing or debating new restrictions on abortion, a trend fueled in part by passage of the nation's new health care law. Both sides of the hot-button issue are seeing new approaches to reduce abortions. … So far, 2010 has been 'very successful,' said Mary Spaulding Balch of the National Right to Life Committee.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
› Verified 8 days ago
Dr. Mark T Wilt, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 401 Rogers St, Princeton, WV 24740 Phone: 304-487-9442 Fax: 330-629-9181 | |
Robert Knox, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 401 Rogers St, Princeton, WV 24740 Phone: 800-292-3008 Fax: 330-629-9181 | |
Dr. Marshal T Gwynn, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 401 Rogers St, Princeton, WV 24740 Phone: 304-487-9442 Fax: 330-536-0069 | |
Dr. Anthony P Zarra, D.P.M Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 401 Rogers St, Princeton, WV 24740 Phone: 304-487-9442 | |
Dr. Douglas Stewart Dockery, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 401 Rogers St, Princeton, WV 24740 Phone: 304-487-9442 Fax: 330-536-0069 | |
Foot And Ankle Clinic Of The Virginias Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 401 Rogers St, Princeton, WV 24740 Phone: 800-292-3008 Fax: 412-291-1552 |